Choosing between TelosRX and Journey for GLP-1 weight loss comes down to two things: how many ways you can take the medication, and what the monthly rate covers. Journey publishes one all-inclusive rate of $179 per month for a once-weekly compounded GLP-1 injection. TelosRX starts as low as $99 per month for semaglutide and offers four GLP-1 paths, including a needle-free one, with quarterly labs included. Both are cash-pay, both run on an online intake, and neither prescribes without a licensed provider signing off.
Want one flat price, thorough published safety information, and a superbill for your insurer? Journey is a clean, well documented option. Want a lower entry price, a choice between weekly injection and daily under-the-tongue dosing, and quarterly labs? TelosRX is the better fit.
Start your intake →Quick comparison: TelosRX vs Journey
Compounded medications are not FDA-approved. Any prescription is subject to medical approval by a licensed provider, and approval is never guaranteed. Pricing and program details are as published by each company at the time of writing.
What is TelosRX?
TelosRX is an online-first, LegitScript-certified telehealth service focused on GLP-1 weight management. It works asynchronously. You complete a short intake, a US-licensed provider reviews it, and there is no appointment to book at any point.
The GLP-1 line covers four paths rather than one. Injectable semaglutide is the entry point at as low as $99 per month. Injectable tirzepatide is as low as $139 per month. There is a needle-free daily oral GLP-1 at $269 per month. For a gentler start, microdosed tirzepatide runs as low as $116 per month. You can see all four side by side on the GLP-1 options page.
Every plan includes unlimited messaging with a 24/7 care team, dose adjustments as your body responds, quarterly labs, and free 2-day discreet shipping. Your rate stays flat as your dose is titrated. If a licensed provider decides a GLP-1 is not right for you, you pay nothing and nothing ships.
Medications are compounded by licensed US pharmacies, and TelosRX names them publicly: VialsRX and Jungle Jim's. Clinical care is delivered through Arora Health Group. You can start your evaluation without booking an appointment.
What is Journey?
Journey, at withjourneyrx.com, describes itself as a telehealth technology platform for clinically guided GLP-1 weight management. It is not a pharmacy and does not manufacture or dispense medication. Clinical care comes from independently owned professional medical corporations, and Journey names that network publicly as LocumTele.
The product is deliberately narrow. Journey offers a compounded GLP-1 program at $179 per month, all-inclusive, covering clinician care, medication, and discreet shipping. Its FAQ states that clinicians may prescribe compounded semaglutide and tirzepatide formulations when clinically appropriate, and that Journey does not dispense controlled substances. Its product page describes a once-weekly subcutaneous injection in the abdomen, thigh, or upper arm, starting at a low dose and titrating up.
The process runs in four steps. You complete a secure online intake that the site says takes 10 to 15 minutes. A US-licensed clinician in your state reviews it. If treatment is appropriate, a plan and prescription go to a partner pharmacy. The medication then ships discreetly, with ongoing access to a care team. Journey names its pharmacy partner as Rush Pharmacy.
Journey serves 48 states. It states plainly that it does not currently operate in South Carolina or California.
Medications: what each program offers
Both services work in the same drug class. Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts on both the GLP-1 and GIP receptors. Both slow gastric emptying and act on appetite signaling. That is the mechanism behind reduced hunger and smaller portions.
The compounded versions offered by both TelosRX and Journey are not FDA-approved. They are prepared by licensed US compounding pharmacies under provider supervision. Neither company offers brand-name Wegovy, Ozempic, Zepbound, or Mounjaro as part of its published program.
The real difference is format. Journey publishes one delivery route, a once-weekly injection. TelosRX publishes four, including a daily under-the-tongue option that removes needles from the routine entirely, and a microdosed tirzepatide protocol for people who want to ease in. If needles are the thing standing between you and starting, that gap matters.
For background on this drug class, see the NIH NIDDK overview of prescription weight-management medications and the FDA's questions and answers on drug compounding.
Key takeaway: Journey does one thing cleanly at one price. TelosRX gives you four ways in, starting $80 a month lower, with labs included.
Pricing and what the rate covers
Both companies publish their pricing openly, which is not something every telehealth brand does. Neither hides a number behind a quiz.
Journey lists a single figure on its homepage: $179 per month, all-inclusive. That covers clinician care, the medication itself, and discreet shipping, with unlimited clinician messaging and no insurance involvement. Its compounded GLP-1 page frames the same figure as "from $179 per month."
TelosRX publishes four rates:
- Semaglutide, injectable, as low as $99 per month
- Microdosed tirzepatide, as low as $116 per month
- Tirzepatide, injectable, as low as $139 per month
- Oral GLP-1, needle-free and daily, $269 per month
On the low end that is an $80 a month gap in favor of TelosRX. On the high end, the needle-free oral option costs more than Journey's injection, which is a fair trade if avoiding needles is worth the difference to you. Both hold one rate rather than raising it as your dose is titrated.
Both are cash-pay and neither bills insurance. Journey adds something TelosRX does not publish: it provides superbills on request that you can submit to your carrier for possible reimbursement. TelosRX plans are FSA and HSA eligible.
One more thing worth reading before you commit to either. Journey's process page says there is no charge to complete the intake and no payment until you are approved. Its refund policy adds three things: evaluation fees are non-refundable once a clinician has begun review, shipped medication cannot be returned, and refunds on unused months of a multi-month subscription are discretionary and pro-rated. TelosRX takes the same position on shipped medication. Charges are final once a prescription is transmitted to the pharmacy, and you are refunded in full if a provider declines you.
Start your intake to see your plan price in a few minutes.
How the process works
The two models are closer here than anywhere else. Both are asynchronous. Neither requires you to book a video visit, and neither prescribes automatically.
With TelosRX, the intake takes about five minutes, a licensed provider reviews it asynchronously, and approved medication ships free with 2-day delivery. Nothing is charged unless you are approved.
Journey describes a longer intake, 10 to 15 minutes, covering medical history, current medications, and goals. A clinician licensed in your state reviews it and may request more information. If a prescription is appropriate, it goes to a partner pharmacy and the medication ships discreetly. Journey is careful to say that submitting an intake does not create a clinician and patient relationship until a clinician accepts your case.
If speed is your priority, TelosRX is the shorter path. If you would rather answer more questions upfront and have that on file, Journey's longer intake is a reasonable trade.
Begin your TelosRX intake and a licensed provider will review it.
Coaching and ongoing support
Neither company sells a heavy coaching layer. There is no nutritionist program, group session schedule, or app-based curriculum published by either one. Support in both cases means access to clinical people.
Journey includes unlimited clinician messaging in the $179 rate, plus regular check-ins and refills as your plan adjusts. It publishes care-team hours, Monday to Friday 8am to 8pm ET and weekends 10am to 4pm ET. It also lists a phone number, which many telehealth brands do not. Email replies are promised within one business day.
TelosRX includes unlimited messaging with a 24/7 care team, dose adjustments as your body changes, and quarterly labs. Journey does not publish a lab program anywhere on its site. If bloodwork tracking matters to you, that is a real difference rather than a marketing one.
Neither approach is automatically better. Journey's published hours and phone line make it easy to know exactly when a human is available. TelosRX keeps the channel open around the clock and folds labs into the plan.
Safety, oversight, and disclosure
Both companies gate medication behind a licensed provider, and both say so clearly. GLP-1 medications are not appropriate for everyone. Providers screen for a personal or family history of medullary thyroid carcinoma, MEN 2, pancreatitis, gallbladder disease, pregnancy and breastfeeding, type 1 diabetes, and active eating disorders. Nausea and digestive changes are common early on.
Journey deserves credit here. Its safety disclosure is more thorough than most of the field. It publishes a dedicated Important Safety Information page and carries the boxed warning for thyroid C-cell tumors in its site footer. It links directly to FDA prescribing information and points patients to FDA MedWatch for adverse-event reporting. It tells you how to verify your clinician's license through docinfo.org or a state board, and publishes a complaint process with a stated acknowledgment and resolution window. It also discloses that some imagery on the site is AI-generated, which is unusual candor.
TelosRX is LegitScript-certified. Journey's LegitScript status is not publicly listed on its site, which is not the same as saying it is uncertified. Plenty of legitimate operators do not display a seal, and the only reliable way to check any company's status is LegitScript's own verification tool.
Both name their pharmacy and clinical partners, which is the disclosure that actually tells you who is handling your prescription. TelosRX names VialsRX and Jungle Jim's for pharmacy and Arora Health Group for clinical care. Journey names Rush Pharmacy and LocumTele.
Ready to compare in practice rather than on paper? Check your eligibility in about five minutes.
Which service is right for you?
Best for a lower entry price, a choice between weekly injection and daily needle-free dosing, quarterly labs included, and LegitScript-certified oversight.
Best for one simple all-inclusive rate, superbills for possible insurance reimbursement, published care-team hours and a phone line, and unusually detailed safety disclosure.
If you are choosing on price, format flexibility, or lab monitoring, TelosRX is the stronger fit. If you value a single flat rate, a documented complaint path, and paperwork you can hand to an insurer, Journey earns a serious look.
Frequently Asked Questions
Is TelosRX legitimate?
Yes. TelosRX is a LegitScript-certified telehealth service. Medications are compounded by licensed US pharmacies, VialsRX and Jungle Jim's, and clinical care is provided through Arora Health Group. Every prescription is subject to medical approval by a licensed provider.
How much does TelosRX cost compared to Journey?
Journey publishes one all-inclusive rate of $179 per month. TelosRX publishes four: semaglutide as low as $99 per month, microdosed tirzepatide as low as $116 per month, injectable tirzepatide as low as $139 per month, and needle-free oral GLP-1 at $269 per month. Both hold your rate flat as your dose is titrated.
Are the GLP-1 medications FDA-approved?
No. The compounded semaglutide and tirzepatide offered by both TelosRX and Journey are not FDA-approved. They are prepared by licensed US compounding pharmacies under provider supervision, and only a licensed provider can decide whether a compounded medication is appropriate for you.
Does Journey offer a needle-free GLP-1?
Journey does not list one. Its compounded GLP-1 page describes a once-weekly subcutaneous injection. TelosRX offers a daily oral GLP-1 taken under the tongue, plus three injectable options.
Which states does Journey serve?
Journey states that it serves 48 US states and does not currently operate in South Carolina or California. Availability of a specific clinician or medication depends on your state of residence at the time of evaluation. TelosRX confirms availability during intake.
Can I switch from Journey to TelosRX?
Many people compare programs before deciding. You can start a new TelosRX intake at any time. A provider reviews your history, current medications, and goals before anything is approved, and you pay nothing if a provider decides a GLP-1 is not right for you.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Any prescription is subject to evaluation by a licensed provider, and approval is never guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service. Competitor details are as published on withjourneyrx.com at the time of writing and may change.
Start your private evaluation at TelosRX, or compare every plan on the GLP-1 options page.